“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...

Amanda Bynes is showing off her new look, revealing to her followers that she recently received lip injections to plump up ...

Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...

Discover why Hims & Hers Health's subscriber growth, profitability, and telehealth expansion make it a strong buy with a ...

As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental oral GLP-1 has prompted weight loss up to ...

And though Hers’s compounded semaglutide is not FDA-approved, she says that every compounded GLP-1 available through the online platform is “made with active pharmaceutical ingredients (APIs ...

That changed with Ozempic, the brand name for semaglutide, Novo Nordisk’s synthetic version of a hormone known as glucagon-like peptide 1, or GLP-1, which helps the body regulate blood sugar levels.

Morley shared: “Novo Nordisk’s oral semaglutide for obesity and Eli Lilly’s orforglipron calcium’s approvals would represent the first oral GLP-1RAs for obesity. “While both products are expected to ...

Weight-loss injections like Mounjaro (tirzepatide) and Wegovy (semaglutide) have gained widespread attention over the past few years as an effective new treatment for weight loss for those living with ...

The market for compounded semaglutide in the U.S. is now roughly “equal” in size to Novo’s own GLP-1 business, the company’s outgoing CEO, Lars Fruergaard Jørgensen, said on a media call ...

In an ongoing preclinical study, substantial progress in the development of a miniature, ultra long-acting, semaglutide implant, NPM-139 has been established by showing weight loss from a single ...

Novo Nordisk has announced the filing of 14 new lawsuits against the sale of unapproved compounded drugs claiming to contain semaglutide, an active ingredient in its weight-loss and diabetes drugs ...